Timpani Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Timpani Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-41,080	Closed	-$3.41M	–	116
2018 Q1	$3.41M	Sell	41,080 -17,792	-30%	-$1.58M	1.19%	35
2017 Q4	$5.36M	Sell	58,872 -14,306	-20%	-$1.19M	1.93%	11
2017 Q3	$5.57M	Buy	73,178 +22,471	+44%	+$1.7M	2.03%	6
2017 Q2	$3.8M	Sell	50,707 -10,010	-16%	-$694K	1.41%	27
2017 Q1	$3.96M	Buy	60,717 +22,753	+60%	+$1.34M	1.59%	19
2016 Q4	$2.09M	Sell	37,964 -1,643	-4%	-$90.2K	0.87%	50
2016 Q3	$2.24M	Buy	+39,607	New	+$1.94M	0.89%	47

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Timpani Capital Management's PRAH Position: Q2 2018 in Review

Timpani Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2018, closing a stake of 41,080 shares — an estimated $3.41M sold.

Timpani Capital Management first reported a position in PRAH in Q3 2016 and held it in 7 quarters. The position peaked at $5.57M in Q3 2017. 300 funds tracked by Wall St. Rank hold PRAH as of Q2 2018.

Timpani Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q2 2018 after selling out during the quarter.
Timpani Capital Management sold 41,080 PRA Health Sciences, Inc. shares in Q2 2018, an estimated $3.41M.
Timpani Capital Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 7 quarters.
Timpani Capital Management's PRA Health Sciences, Inc. position peaked at $5.57M in Q3 2017.
300 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2018.

Based on Timpani Capital Management's 13F filing for Q2 2018, filed 10 Aug 2018.